Contact
Please use this form to send email to PR contact of this press release:
RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines
TO:
Please use this form to send email to PR contact of this press release:
RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines
TO: